Categories: NewsPharmaceutical

ciATHENA-Powered Market Mix Modeling: 98% Faster Insights and 70% Lower Cost for Pharma Marketers

SCOTTSDALE, Ariz., Oct. 29, 2025 /PRNewswire/ — CustomerInsights.AI (CIAI) today announced the launch of ciATHENA’s Market Mix Modeling (MMM) use case: the pharma industry’s first Agentic AI-powered MMM platform, setting new benchmarks for insights, speed, and cost efficiency in life sciences marketing.

Pharma marketers often experience significant delays with traditional MMM, waiting weeks or even months for insights into channel performance, which hinders timely decision-making and action. These slow and retrospective analyses mean that marketers may miss critical market events, such as new payer contracts or competitor product launches, only discovering their impact when it’s too late to respond effectively.

Traditional MMM in the pharmaceutical industry struggles with fragmented, hard-to-integrate data, leading to missed market shifts and making it difficult for pharma marketers to adapt strategies in real time.

Purpose-built for Pharma, ciATHENA MMM redefines Marketing Analytics. The use case generates actionable, persona-driven insights up to 98% faster and at 70% lower costs than traditional approaches, delivering answers in just hours, not months, empowering marketing leaders to act at true market speed.

We’ve seen Pharma teams lose millions while waiting for MMM answers that arrive too late. We knew something had to change,” said Ankit Chhabra, Chief Product Officer of CIAI. ciATHENA MMM empowers marketers to move at the speed of the market, asking questions naturally and getting actionable answers instantly.”

ciATHENA MMM: Self-Service Conversational Intelligence for Pharma Marketers
ciATHENA MMM is an industry-first use case built to transform marketing and customer engagement decisions at market speed. Users can ask plain-English questions such as “Which channel drove maximum prescription lift this quarter?” and receive contextual, explainable answers instantly. Some of the other key differentiators include:

  • Autonomous, conversational answers in plain English
  • Real-time adaptability to market triggers
  • Intelligent budget simulations for optimization

ciATHENA MMM moves commercial teams from justifying the mix to continuously improving it,” said Darren Lenczycki, Client Partner, Commercialization Strategy. “Our use case learns, adapts, and tailors its insights for marketers, brand managers, analytics leaders, extending even to enterprise-wide insights, delivering market-ready decisions on demand.”

Click here  to learn more about the ciATHENA MMM use case.

About CustomerInsights.AI (CIAI)
Launched in 2018, CIAI is a Platform-led Analytics as a Service (PLAaaS) company disrupting the Life Sciences analytics ecosystem through AI-powered commercial analytics applications to Pharmaceutical and Biotech clients.

For more information, visit CustomerInsights.AI or follow us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ciathena-powered-market-mix-modeling-98-faster-insights-and-70-lower-cost-for-pharma-marketers-302598395.html

SOURCE CustomerInsights.AI

Staff

Recent Posts

10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference

PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell…

3 hours ago

Tri-City Cardiology’s Ambulatory Surgical Center Surpasses 6,000 Procedures, Marking a Major Milestone in Outpatient Cardiovascular Care

MESA, Ariz., Dec. 29, 2025 /PRNewswire/ -- Tri-City Cardiology's Ambulatory Surgical Center (ASC), legally referred to…

3 hours ago

LG NOVA UNVEILS NEXT GENERATION OF AI-FIRST VENTURES AT CES 2026

Collaborative AI-First Ventures Delivers Impactful Solutions for Health, Energy, Small Business and Enterprise SectorsLAS VEGAS,…

3 hours ago

Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…

3 hours ago

Through High-Profile Ambassadors and Major Partnerships, ZetrOZ Systems Expanded Reach of sam Device in 2025

The leader in sports medicine healing innovations worked with athletes, athletic trainers, physicians and foundations…

6 hours ago